Results 241 to 250 of about 4,921,476 (300)
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
Lung Cancer Chemoresistance: Insights into the Regulatory Role of lncRNAs. [PDF]
Hou M +5 more
europepmc +1 more source
Lung Cancer Awareness Among Adults in Riyadh, Saudi Arabia: A Cross-Sectional Study Using the Lung Cancer Awareness Measure (CAM). [PDF]
Salem SS +8 more
europepmc +1 more source
Lung cancer screening in transition: highlights from the 3rd Oslo Lung Cancer Symposium, 2025. [PDF]
Khalife G +10 more
europepmc +1 more source
Microbiome as a prediction of immunotherapy response in lung cancer. [PDF]
Rojas L, Zuluaga J, Cardona AF.
europepmc +1 more source
Erratum: Chinese expert consensus on day surgery management of lung cancer (2024 edition).
Editorial Office of Chinese Journal of Lung Cancer
doaj +1 more source

